Which medication is NOT typically used for treating fungal infections?

Palivizumab is monoclonal antibody primarily used for the prevention of respiratory syncytial virus (RSV) infections in high-risk pediatric populations, such as premature infants and children with certain underlying health conditions. It does not possess antifungal properties or efficacy against fungal infections.

In contrast, Fluconazole, Itraconazole, and Amphotericin B are established antifungal medications. Fluconazole and Itraconazole are azole antifungals that inhibit fungal cell membrane synthesis. Amphotericin B, a polyene antibiotic, binds to ergosterol in fungal cell membranes, leading to cell death. Thus, the correct choice highlights Palivizumab as it does not belong to the category of antifungal medications, distinguishing it from the other options that are all used to treat fungal infections.